Case Series
This article aims to report very long-term data of patients with severe eosinophilic asthma assessing asthma control, lung function, inhaled corticosteroid dose reduction and clinical and biological parameters of patients treated with mepolizumab.
Review
This article describes a case of severe hypereosinophilia in a patient with chronic rhinosinusitis with nasal polyps and asthma treated with dupilumab and a subsequent therapeutic shift to mepolizumab that led to maintenance of symptom control and concomitant normalization of blood eosinophil count.
Case Report
This article presents a case of ICEP in which mepolizumab was used as a steroid-sparing agent, resulting in improvement in markers of disease activity
and corticosteroid requirement.
Review
This review summarizes the rationale for the use of biologics in eosinophilic diseases and their mechanisms of action.
Original Research
This article analyses the effectiveness, clinical outcomes, and safety of mepolizumab in clinical practice.
